Miravant Medical Technologies

Miravant Medical Technologies, formerly PDT, Inc., is engaged in the integrated development of drugs and medical device products for use in PhotoPoint(TM), their proprietary technologies for photodynamic therapy. PhotoPoint is a medical procedure which integrates the use of proprietary light-activated drugs, proprietary light producing devices and light delivery devices to achieve selective photochemical destruction of diseased cells. Miravant Medical Technologies believe that PhotoPoint has the potential to be a safe, cost-effective, minimally invasive primary or adjunctive treatment for indications in a broad number of disease areas, including oncology, ophthalmology, urology, dermatology and cardiovascular disease. Miravant Medical Technologies are currently conducting clinical trials in ophthalmology and oncology. Miravant Medical Technologies current clinical trials are testing our leading drug candidate, SnET2 (tin ethyl etiopurpurin).

Contact Details: 336 Bollay Drive Santa Barbara CA 93117 United States of America Tel: 805 685 9880 Fax: 805 685 2959 Email: WWW: www.pdti.com/

Loading...

Recent Publications by Miravant Medical Technologies:
PhotoPoint photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models. PURPOSE: To demonstrate the feasibility of PhotoPoint photodynamic therapy...	6th December, 2003	Miravant Medical Technologies, 336 Bollay Drive, Santa Barbara, CA	Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):163-8.
PhotoPoint photodynamic therapy inhibits intimal hyperplasia in arteriovenous access grafts. PURPOSE: To evaluate the ability of PhotoPoint photodynamic therapy (PDT)...	6th December, 2003	Miravant Medical Technologies Inc., 336 Bollay Drive, Goleta, CA	Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):147-51.

BioNews Results for Miravant Medical Technologies:
Semi-Annual Changes to the NASDAQ Biotechnology Index	World Market Media:  Nov 14 2009 11:33PM Matching: medical technologies
Semi-Annual Changes to the NASDAQ Biotechnology Index	Review Seeker:  Nov 14 2009 9:41AM Matching: medical technologies
Semi-Annual Changes to the NASDAQ Biotechnology Index	RBC Dain Rauscher:  Nov 14 2009 4:53AM Matching: medical technologies
Trial Examines Whether Stem Cells Can Treat Critical Limb Ischemia	Diagnostic & Invasive Cardiology:  Nov 14 2009 2:10AM Matching: medical technologies
Semi-Annual Changes to the NASDAQ Biotechnology Index	Media Workstation:  Nov 14 2009 1:40AM Matching: medical technologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Miravant Medical Technologies news.

Miravant Medical Technologies Patents:
US Patent No.	Title
6783541	Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
6138046	Dosimetry probe

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1568 times since April 2007, the link to the organisation's website has been followed 335 times

Recent Search Terms used to find this page: miravant medical technologies santa barbara ca | Miravant Medical Technologies website | Miravant Medical Technologies | Miravant Medical Technologies | Miravant Medical Technologies | Miravant Medical Tech | miravant medical technologies santa barbara ca | Miravant | m ravant med news | miravant medical technologies logo | .

Search for more companies in Santa Barbara

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Miravant Medical Technologies